title: Outcomes of high initial daily doses of gonadotropin in patients with poor ovarian reserve.
abstract: OBJECTIVE
  To evaluate the in vitro fertilization and intracytoplasmic sperm injection outcomes after high initial doses of follicle-stimulating hormone (FSH) in patients with poor ovarian reserve.
  
  
  METHODS
  For in vitro fertilization/intracytoplasmic sperm injection patients younger than 40 years of age, 345 cycles were examined from April 2003 to April 2007. As a control, 218 cycles received gonadotropin-releasing hormone agonist and regular initial doses of FSH from day 3 of the treated cycle. The remaining 127 cycles were treated with high initial doses of FSH with an antagonist or low doses of gonadotropin-releasing hormone because of poor ovarian reserve.
  
  
  RESULTS
  When higher initial doses of FSH were used, lower estradiol levels on the day of human chorionic gonadotropin injection and less mature oocytes were retrieved from the group with poor ovarian reserve. Clinical pregnancy rates per embryo transfer were similar (45.7%vs. 48.2%, p = 0.686). There was a trend of lower ongoing pregnancy rate per cycle (28.3%vs. 38.5%, p = 0.05) in the study compared with the control group. In the subgroups with high doses of FSH, neither protocol was superior in terms of clinical (45.5%vs. 46.2%, p=0.952) or ongoing pregnancy rates per embryo transfer (37.9%vs. 42.3%, p=0.695).
  
  
  CONCLUSIONS
  There was no significant difference in clinical pregnancy rate of the two groups when good embryos were obtained. The group with poor ovarian reserve had lower ongoing pregnancy rates per cycle. For patients with expected poor ovarian response, treatment with high doses of FSH initially is an option.
authors.affiliation: Department of Obstetrics and Gynecology, Taipei Medical University, Taipei, Taiwan.
authors.forename: Li-Ling
authors.initials: LL
authors.lastname: Chou
authors.forename: Yuh-Ming
authors.initials: YM
authors.lastname: Hwu
authors.forename: Ming-Huei
authors.initials: MH
authors.lastname: Lin
authors.forename: Shyr-Yeu
authors.initials: SY
authors.lastname: Lin
authors.forename: Robert Kuo-Kuang
authors.initials: RK
authors.lastname: Lee
mesh_terms: D000328:Adult; D016009:Chi-Square Distribution; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology; D010064:Embryo Implantation; D004624:Embryo Transfer; D004958:Estradiol / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage* / Q000494:pharmacology; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006801:Humans; D007247:Infertility, Female; D016729:Leuprolide / Q000008:administration & dosage; D008596:Menotropins / Q000008:administration & dosage / Q000494:pharmacology; D009865:Oocytes / Q000187:drug effects; D006080:Ovarian Follicle / Q000254:growth & development; D011247:Pregnancy; D018873:Pregnancy Rate; D012189:Retrospective Studies; D020554:Sperm Injections, Intracytoplasmic / Q000379:methods; D016896:Treatment Outcome
chemical_list: D006063:Chorionic Gonadotropin; D007987:Gonadotropin-Releasing Hormone; D004958:Estradiol; D008596:Menotropins; D005640:Follicle Stimulating Hormone; D016729:Leuprolide